SCHEMBL6986909

SCHEMBL6986909

CC(C)(C)OC(=O)NCCNc1cccc(OC(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.52
MTNR1B P49286 1/20 0.52
MALT1 Q9UDY8 1/20 0.46
BCHE P06276 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
FLT1 P17948 1/20 0.43
KDR P35968 1/20 0.43
P2RX1 P51575 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10126895 0.87 MTNR1A (0.69) MTNR1AMTNR1BMALT1BCHENPC1
SCHEMBL29991055 0.83 NPC1 (0.55) NPC1RAB9AALDH1A1GAAMAPT
SCHEMBL27833511 0.83 NPC1 (0.55) NPC1RAB9AALDH1A1GAAMAPT
SCHEMBL10126690 0.81 MTNR1A (0.60) MTNR1AMTNR1BALDH1A1MAPTHTT
SCHEMBL5891961 0.81 MAPK1 (0.53) MTNR1AMTNR1BMALT1BCHEALDH1A1
SCHEMBL19591348 0.81 MALT1 (0.49) MTNR1AMTNR1BMALT1BCHEALDH1A1
SCHEMBL16011811 0.81 MALT1 (0.49) MTNR1AMTNR1BMALT1BCHEALDH1A1
SCHEMBL8392596 0.80 AAK1 (0.45) NPC1RAB9ALMNAPOLBSLC22A12
SCHEMBL7203913 0.80 MALT1 (0.59) MALT1BCHEGAACA1CA2
SCHEMBL18526150 0.80 MAPK14 (0.58) CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1276726-A2 SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS Abbott Laboratories (US) 2003-01-22 EP disclosed
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed
WO-2001081316-A2 SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS ABBOTT LABORATORIES (US) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 MTNR1A 2751/4885MTNR1B 2421/4885MALT1 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.